This Article Full Text Full Text (PDF) Supplemental Data All Versions of this Article: 22/1/78    most recent Author Manuscript (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager NURSA Molecule Pages Link Request Copyright Permission Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Hwang-Verslues, W. W. Articles by Sladek, F. M. Search for Related Content PubMed PubMed Citation Articles by Hwang-Verslues, W. W. Articles by Sladek, F. M.

Nuclear Receptor Hepatocyte Nuclear Factor 41 Competes with Oncoprotein c-Myc for Control of the p21/WAF1 Promoter

Environmental Toxicology Graduate Program (W.W.H.-V.) and Department of Cell Biology and Neuroscience (F.M.S.), University of California, Riverside, California 92521

Address all correspondence and requests for reprints to: Frances M. Sladek, Ph.D., Department of Cell Biology and Neuroscience, 2115 Biological Sciences Building, University of California, Riverside, California 92521. E-mail: frances.sladek{at}ucr.edu.

The dichotomy between cellular differentiation and proliferation is a fundamental aspect of both normal development and tumor progression; however, the molecular basis of this opposition is not well understood. To address this issue, we investigated the mechanism by which the nuclear receptor hepatocyte nuclear factor 41 (HNF41) regulates the expression of the human cyclin-dependent kinase inhibitor gene p21/WAF1 (CDKN1A). We found that HNF41, a transcription factor that plays a central role in differentiation in the liver, pancreas, and intestine, activates the expression of p21 primarily by interacting with promoter-bound Sp1 at both the proximal promoter region and at newly identified sites in a distal region (–2.4 kb). Although HNF41 also binds two additional regions containing putative HNF4 binding sites, HNF41 mutants deficient in DNA binding activate the p21 promoter to the same extent as wild-type HNF41, indicating that direct DNA binding by HNF41 is not necessary for p21 activation. We also observed an in vitro and in vivo interaction between HNF41 and c-Myc as well as a competition between these two transcription factors for interaction with promoter-bound Sp1 and regulation of p21. Finally, we show that c-Myc competes with HNF41 for control of apolipoprotein C3 (APOC3), a gene associated with the differentiated hepatic phenotype. These results suggest a general model by which a differentiation factor (HNF41) and a proliferation factor (c-Myc) may compete for control of genes involved in cell proliferation and differentiation.

NURSA Molecule Pages Link:

Nuclear Receptors:   HNF4α